YM 872: Clinical Trials

2 trials of YM 872, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow YM 872: new trials by email Literature Review of YM 872 trials Research Report on YM 872

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Effects of YM872 on Stroke Lesion Volume in Acute Stroke Patients
YM872 (zonampanel) - Cerebrovascular Accident
Phase 2CompletedAstellas Pharma Inc2000-12-012006-04-03
A Study to Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator)
YM872 (zonampanel), t-PA (alteplase) - Acute Ischemic Stroke
Phase 2CompletedAstellas Pharma Inc2000-12-012006-04-03

Conditions studied

Ischemic Stroke (2)  ·  Stroke (1)

Sponsors

Astellas Pharma Inc (2)

Countries

Austria (2)  ·  Belgium (2)  ·  Canada (2)  ·  Germany (2)  ·  United States (2)  ·  South Africa (1)